MicroGen NIPT

What is NIPT?
NIPT uses a blood sample from the mother to analyze DNA from the placenta for certain chromosome conditions, like Down syndrome, that could affect the baby’s health. During pregnancy, some of the DNA from the placenta, which carries the baby's genetic information, crosses into mother’s bloodstream.

The test identified the usual number of copies of the chromosomes. This indicates your pregnancy is unlikely to be affected by the aneuploidies tested.

The test identified too many or too few copies of one of the chromosomes. This indicates your pregnancy may be affected by the aneuploidies tested and it is highly recommended to confirm with an invasive diagnostic follow up test, such as CVS or amniocentesis to eliminate the possibility of a false result.

The test showed a borderline result which was inconclusive. This could be due to many reasons, for example, blood sample contains low levels of fetal DNA. In such cases, Micro Health Laboratories will offer a redraw, free of charge, a week later to rerun the test. 

For more information, you may download our newsletter below.